- Headquarters
- Cambridge, Massachusetts, United States · North America
- Value chain
- Research & IP(Research & design)
- What that means
- Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
- Founded
- 2013
- Ownership
- Listed
- Listing
- Nasdaq:EDIT on Google Finance
- Website
- editasmedicine.com
- Relevance
- Moderate at its strongest, in Synthetic Biology & Genetic Engineering
Cambridge, Massachusetts, United StatesIn 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Research · listed #19 of 50
Early CRISPR gene-editing company holding exclusive licences to Broad Institute Cas9 and Cas12a patents, now focused on in vivo editing.
Relevance: Early CRISPR company with key licences, diminished